Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Intraperitoneal gemcitabine pharmacokinetics: a pilot and pharmacokinetic study in patients with advanced adenocarcinoma of the pancreas.

Gamblin TC, Egorin MJ, Zuhowski EG, Lagattuta TF, Herscher LL, Russo A, Libutti SK, Alexander HR, Dedrick RL, Bartlett DL.

Cancer Chemother Pharmacol. 2008 Sep;62(4):647-53. Epub 2007 Nov 27.

PMID:
18040687
2.

A pilot study of longitudinal serum cytokine and angiogenesis factor levels as markers of therapeutic response and survival in patients with head and neck squamous cell carcinoma.

Druzgal CH, Chen Z, Yeh NT, Thomas GR, Ondrey FG, Duffey DC, Vilela RJ, Ende K, McCullagh L, Rudy SF, Muir C, Herscher LL, Morris JC, Albert PS, Van Waes C.

Head Neck. 2005 Sep;27(9):771-84.

PMID:
15920746
3.

Phase I study of weekly gemcitabine as a radiation sensitizer for unresectable pancreatic cancer.

Poggi MM, Kroog GS, Russo A, Muir C, Cook J, Smith J, Mitchell JB, Herscher LL.

Int J Radiat Oncol Biol Phys. 2002 Nov 1;54(3):670-6.

PMID:
12377317
4.

Concurrent paclitaxel and radiation in the treatment of locally advanced head and neck cancer.

Sunwoo JB, Herscher LL, Kroog GS, Thomas GR, Ondrey FG, Duffey DC, Solomon BI, Boss C, Albert PS, McCullugh L, Rudy S, Muir C, Zhai S, Figg WD, Cook JA, Mitchell JB, Van Waes C.

J Clin Oncol. 2001 Feb 1;19(3):800-11.

PMID:
11157034
5.

Safety and efficacy of adenovirus-mediated transfer of the human aquaporin-1 cDNA to irradiated parotid glands of non-human primates.

O'Connell AC, Baccaglini L, Fox PC, O'Connell BC, Kenshalo D, Oweisy H, Hoque AT, Sun D, Herscher LL, Braddon VR, Delporte C, Baum BJ.

Cancer Gene Ther. 1999 Nov-Dec;6(6):505-13.

6.

Principles of chemoradiation: theoretical and practical considerations.

Herscher LL, Cook JA, Pacelli R, Pass HI, Russo A, Mitchell JB.

Oncology (Williston Park). 1999 Oct;13(10 Suppl 5):11-22. Review.

7.

Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer.

Chen Z, Malhotra PS, Thomas GR, Ondrey FG, Duffey DC, Smith CW, Enamorado I, Yeh NT, Kroog GS, Rudy S, McCullagh L, Mousa S, Quezado M, Herscher LL, Van Waes C.

Clin Cancer Res. 1999 Jun;5(6):1369-79.

8.

Taxanes as radiosensitizers for head and neck cancer.

Herscher LL, Cook J.

Curr Opin Oncol. 1999 May;11(3):183-6. Review.

PMID:
10328592
9.

Phase I study of paclitaxel as a radiation sensitizer in the treatment of mesothelioma and non-small-cell lung cancer.

Herscher LL, Hahn SM, Kroog G, Pass H, Temeck B, Goldspiel B, Cook J, Mitchell JB, Liebmann J.

J Clin Oncol. 1998 Feb;16(2):635-41.

PMID:
9469352
10.

Protection against SR 4233 (Tirapazamine) aerobic cytotoxicity by the metal chelators desferrioxamine and tiron.

Herscher LL, Krishna MC, Cook JA, Coleman CN, Biaglow JE, Tuttle SW, Gonzalez FJ, Mitchell JB.

Int J Radiat Oncol Biol Phys. 1994 Nov 15;30(4):879-85.

PMID:
7960991
11.

National Cancer Institute (phase II) study of high-grade glioma treated with accelerated hyperfractionated radiation and iododeoxyuridine: results in anaplastic astrocytoma.

Sullivan FJ, Herscher LL, Cook JA, Smith J, Steinberg SM, Epstein AH, Oldfield EH, Goffman TE, Kinsella TJ, Mitchell JB, et al.

Int J Radiat Oncol Biol Phys. 1994 Oct 15;30(3):583-90.

PMID:
7928489
12.

Myocytolysis (vacuolar degeneration) of myocardium: immunohistochemical evidence of viability.

Edwalds GM, Said JW, Block MI, Herscher LL, Siegel RJ, Fishbein MC.

Hum Pathol. 1984 Aug;15(8):753-6.

PMID:
6204921
13.

Distribution of LDH-1 in normal, ischemic, and necrotic myocardium. An immunoperoxidase study.

Herscher LL, Siegel RJ, Said JW, Edwalds GM, Moran MM, Fishbein MC.

Am J Clin Pathol. 1984 Feb;81(2):198-203.

PMID:
6198900

Supplemental Content

Loading ...
Support Center